CoChat

Self-monitoring and self-management of oral anticoagulation

Garcia-Alamino, Josep M, Ward, Alison M, Alonso-Coello, Pablo, Perera, Rafael, Bankhead, Clare, Fitzmaurice, David, Heneghan, Carl J · 2010 · Cochrane Database of Systematic Reviews
Cited by 109

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The introduction of portable monitors (point-of-care devices) for the management of patients on oral anticoagulation allows self-testing by the patient at home. Patients who self-test can either adjust their medication according to a pre-determined dose-INR schedule (self-management) or they can call a clinic to be told the appropriate dose adjustment (self-monitoring). Several trials of self-monitoring of oral anticoagulant therapy suggest this may be equal to or better than standard monitoring. OBJECTIVES: To evaluate the effects of self-monitoring or self-management of oral anticoagulant therapy compared to standard monitoring. SEARCH STRATEGY: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2007, Issue 4), MEDLINE, EMBASE and CINAHL (to November 2007). We checked bibliographies and contacted manufacturers and authors of relevant studies. No language restrictions were applied. SELECTION CRITERIA: Outcomes analysed were thromboembolic events, mortality, major haemorrhage, minor haemorrhage, tests in therapeutic range, frequency of testing, and feasibility of self-monitoring and self-management. DATA COLLECTION AND ANALYSIS: The review authors independently extracted data. We used a fixed-effect model with the Mantzel-Haenzel method to calculate the pooled risk ratio (RR) and Peto's method to verify the results for uncommon outcomes. We examined heterogeneity amongst studies with the Chi(2) and I(2) statistics. MAIN RESULTS: We identified 18 randomized trials (4723 participants). Pooled estimates showed significant reductions in both thromboembolic events (RR 0.50, 95% CI 0.36 to 0.69) and all-cause mortality (RR 0.64, 95% CI 0.46 to 0.89). This reduction in mortality remained significant after the removal of low-quality studies (RR 0.65, 95% CI 0.46 to 0.90). Trials of self-management alone showed significant reductions in thromboembolic events (RR 0.47, 95% CI 0.31 to 0.70) and all-cause mortality (RR 0.55, 95% CI 0.36 to 0.84); self-monitoring did not (thrombotic events RR 0.57, 95% CI 0.32 to 1.00; mortality RR 0.84, 95% CI 0.50 to 1.41). Self-monitoring significantly reduced major haemorrhages (RR 0.56, 95% CI 0.35 to 0.91) whilst self-management did not (RR 1.12, 95% CI 0.78 to 1.61). Twelve trials reported improvements in the percentage of mean INR measurements in the therapeutic range. No heterogeneity was identified in any of these comparisons. AUTHORS' CONCLUSIONS: Compared to standard monitoring, patients who self-monitor or self-manage can improve the quality of their oral anticoagulation therapy. The number of thromboembolic events and mortality were decreased without increases in harms. However, self-monitoring or self-management were not feasible for up to half of the patients requiring anticoagulant therapy. Reasons included patient refusal, exclusion by their general practitioner, and inability to complete training.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd003839.pub2

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 87

  1. Beyth, 2000, A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial, Annals of Internal Medicine, 133, 687, 10.7326/0003-4819-133-9-200011070-00010 · DOI · Paper page
  2. Christensen, 2006, Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial, European Journal of Internal Medicine, 17, 260, 10.1016/j.ejim.2005.11.021 · DOI
  3. Cromheecke, 2000, Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison, Lancet, 356, 97, 10.1016/S0140-6736(00)02470-3 · DOI · Paper page
  4. Fitzmaurice, 2002, A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management, Journal of Clinical Pathology, 55, 845, 10.1136/jcp.55.11.845 · doi:10.1136/jcp.55.11.845
  5. Fitzmaurice, 2005, Self management of oral anticoagulation: randomised trial, BMJ, 331, 1057, 10.1136/bmj.38618.580903.AE · DOI
  6. McCahon, 2003, SMART: self-management of anticoagulation, a randomised trial, BMC Family Practice, 4, 11, 10.1186/1471-2296-4-11 · DOI
  7. Murray, 2004, Training for patients in a randomised controlled trial of self management of warfarin treatment, BMJ, 328, 437, 10.1136/bmj.328.7437.437 · DOI
  8. Gadisseur, 2003, Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial, Archives of Internal Medicine, 163, 2639, 10.1001/archinte.163.21.2639 · DOI
  9. Gadisseur, 2004, Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life, Journal of Thrombosis and Haemostasis, 2, 584, 10.1111/j.1538-7836.2004.00659.x · DOI
  10. Gadisseur, 2003, Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial, Archives of Internal Medicine, 163, 2639, 10.1001/archinte.163.21.2639 · DOI
  11. Gadisseur, 2004, Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life, Journal of Thrombosis and Haemostasis, 2, 584, 10.1111/j.1538-7836.2004.00659.x · DOI
  12. Gardiner, 2005, Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring, British Journal of Haematology, 128, 242, 10.1111/j.1365-2141.2004.05300.x · DOI
  13. Horstkotte, 1998, Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease, Journal of Thrombosis and Thrombolysis, 5 Suppl 1, 19, 10.1023/A:1013228718768 · doi:10.1023/a:1013228718768
  14. Kaatz, 2001, Anticoagulation therapy home andoffice monitoring evaluation study, Journal of Thrombosis and Thrombolysis, 12, 111
  15. Khan, 2004, The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation, British Journal of Haematology, 126, 557, 10.1111/j.1365-2141.2004.05074.x · DOI · Paper page
  16. Koertke, 2000, INR self-management following mechanical heart valve replacement, Journal of Thrombosis and Thrombolysis, 9 Suppl 1, 41, 10.1023/A:1018712520472 · doi:10.1023/a:1018712520472
  17. Koertke, 2003, INR self-management permits lower anticoagulation levels after mechanical heart valve replacement, Circulation, 108, II
  18. Körtke, 2001, International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?, Annals of Thoracic Surgery, 72, 44, 10.1016/S0003-4975(01)02656-X · doi:10.1016/s0003-4975(01)02656-x
  19. Körtke, 2001, INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial), Zeitschrift fur Kardiologie, 90 Suppl, 6118
  20. Menéndez-Jándula, 2005, Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial, Annals of Internal Medicine, 142, 1, 10.7326/0003-4819-142-1-200501040-00006 · DOI · Paper page
  21. Sawicki, 1999, A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation, JAMA, 281, 145, 10.1001/jama.281.2.145 · DOI · Paper page
  22. Sawicki, 2003, Long-term results of patients' self-management of oral anticoagulation, Journal of Clinical & Basic Cardiology, 6, 59
  23. Sidhu, 2001, Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients, Annals of Thoracic Surgery, 72, 1523, 10.1016/S0003-4975(01)03049-1 · doi:10.1016/s0003-4975(01)03049-1
  24. Siebenhofer, 2007, Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial, Thrombosis and Haemostasis, 97, 408, 10.1160/TH06-08-0482 · DOI
  25. Sunderji, 1999, Outpatient self-management of warfarin therapy: A pilot study, Pharmacotherapy, 19, 787, 10.1592/phco.19.9.787.31546 · doi:10.1592/phco.19.9.787.31546
  26. Sunderji, 2004, A randomized trial of patient self-managed versus physician-managed oral anticoagulation, Canadian Journal of Cardiology, 20, 1117
  27. Völler, 2005, Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study), Zeitschrift fur Kardiologie, 94, 182, 10.1007/s00392-005-0199-0 · DOI
  28. White, 1989, Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study, Annals of Internal Medicine, 111, 730, 10.7326/0003-4819-111-9-730 · doi:10.7326/0003-4819-111-9-730
  29. Christensen, 2001, Self-management of oral anticoagulant therapy for mechanical heart valve patients, Scandinavian. Cardiovascular Journal, 35, 107, 10.1080/140174301750164772 · doi:10.1080/140174301750164772
  30. Christensen, 2003, Mechanical heart valve patients can manage oral anticoagulant therapy themselves, European Journal of Cardio-Thoracic Surgery, 23, 292, 10.1016/s1010-7940(02)00817-5 · doi:10.1016/s1010-7940(02)00817-5
  31. Hambleton, 2003, Home monitoring of anticoagulation, Journal of Thrombosis and Thrombolysis, 16, 39, 10.1023/B:THRO.0000014591.32012.1f · doi:10.1023/b:thro.0000014591.32012.1f
  32. Hasenkam, 1997, Practicability of patient self-testing of oral anticoagulant therapy by the international normalized ratio (INR) using a portable whole blood monitor. A pilot investigation, Thrombosis Research, 85, 77, 10.1016/S0049-3848(96)00224-1 · doi:10.1016/s0049-3848(96)00224-1
  33. Hasenkam, 1998, Self management of peroral anticoagulant therapy in patients with artificial heart valves, Ugeskrift for Laeger, 160, 6811
  34. Heidinger, 2000, Clinical outcome of self-management of oral anticoagulation in patients with atrial fibrillation or deep vein thrombosis, Thrombosis Research, 98, 287, 10.1016/S0049-3848(00)00181-X · doi:10.1016/s0049-3848(00)00181-x
  35. Horstkotte, 2004, Improvement of oral anticoagulation therapy by INR self-management, Journal of Heart Valve Disease, 13, 335
  36. Lafata, 2000, Anticoagulation clinics and patient self-testing for patients on chronic warfarin therapy: A cost-effectiveness analysis, Journal of Thrombosis and Thrombolysis, 9 Suppl 1, 13, 10.1023/A:1018704318655 · DOI
  37. Leger, 2004, Therapeutic education of patients receiving anticoagulants for thromboembolic venous disease: Description of the Educ'AVK program, Journal des Maladies Vasculaires, 29, 145, 10.1016/S0398-0499(04)96736-4 · doi:10.1016/s0398-0499(04)96736-4
  38. Levi, 2001, Self-monitoring and self dosing of oral anticoagulant therapy with vitamin K antagonists, Tijdschrift voor Geneeskunde, 145, 2313
  39. Piso, 2002, The quality of oral anticoagulation before, during and after a period of patient self-management, Thrombosis Research, 106, 101, 10.1016/S0049-3848(02)00098-1 · doi:10.1016/s0049-3848(02)00098-1
  40. Rosengart, 2002, Anticoagulation self-testing after heart valve replacement, Journal of Heart Valve Disease, 11 Suppl, 61
  41. Schmidtke, 2001, Quality of life after aortic valve replacement - Anticoagulation self-management or conventional therapy in mechanical prostheses versus pulmonary autograft, Zeitschrift fur Kardiologie, 90, 860, 10.1007/s003920170084 · doi:10.1007/s003920170084
  42. Sunderji, 2005, Clinical impact of point-of-care vs laboratory measurement of anticoagulation, American Journal of Clinical Pathology, 123, 184, 10.1309/P2Y3VM4AXPVUDAW3 · doi:10.1309/p2y3vm4axpvudaw3
  43. Watzke, 2000, A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation, Thrombosis and Haemostasis, 84, 931
  44. Matchar, 2005, The impact of patient self-testing of prothrombin time for managing anticoagulation: rationale and design of VA Cooperative Study #481--the Home INR Study (THINRS) [Protocol], Journal of Thrombosis and Thrombolysis, 19, 163, 10.1007/s11239-005-1452-0 · DOI
  45. Anderson, 1993, Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy, Archives of Internal Medicine, 153, 1441, 10.1001/archinte.1993.00410120027004 · doi:10.1001/archinte.1993.00410120027004
  46. Ansell, 1996, Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management, American Heart Journal, 132, 1095, 10.1016/S0002-8703(96)90040-X · DOI
  47. Ansell, 2001, Managing oral anticoagulant therapy, Chest, 119 Suppl, 22, 10.1378/chest.119.1_suppl.22S · DOI · Paper page
  48. Ansell, 2004, The pharmacology and management of the vitamin K antagonist, Chest, 126, 204, 10.1378/chest.126.3_suppl.204S · DOI · Paper page
  49. Ansell, 2005, Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation, International Journal of Cardiology, 99, 37, 10.1016/j.ijcard.2003.11.008 · DOI
  50. Baglin, 1994, Decentralization of anticoagulant control, Clinical and Laboratory Haematology, 16, 327
  51. Bazian, Self-management of oral anticoagulation, Evidence-Based Healthcare and Public Health, 9, 334
  52. Breckenridge, 1978, Oral anticoagulant drugs: pharmacokinetic aspects, Seminars in Hematology, 15, 19
  53. Brown A Wells P Jaffey J McGahan L Poon M-C Cimon K Point-of-care monitoring devices for long-term oral anticoagulation therapy: clinical and cost effectiveness Canadian Agency for Drugs and Technologies in Health 2007 · DOI
  54. Buckingham, 2002, Anticoagulants for atrial fibrillation: why is the treatment rate so low?, Clinical Cardiology, 25, 447, 10.1002/clc.4960251003 · DOI
  55. Cannegieter, 1995, Optimal oral anticoagulant therapy in patients with mechanical heart valves, New England Journal of Medicine, 333, 11, 10.1056/NEJM199507063330103 · DOI · Paper page
  56. Caro, 2004, An economic model of stroke in atrial fibrillation: the cost of suboptimal oral anticoagulation, The American Journal of Managed Care, 10, 451
  57. Christensen, 2007, Self-management of oral anticoagulant therapy: a systematic review and meta-analysis, International Journal of Cardiology, 118, 54, 10.1016/j.ijcard.2006.06.018 · DOI
  58. Christensen, 2009, International normalised ratio (INR) measured on the CoaguChek S and XS compared with the laboratory for determination of precision and accuracy, Thrombosis and Haemostasis, 101, 563, 10.1160/TH08-09-0601 · DOI
  59. Connolly, 1991, Canadian Atrial Fibrillation Anticoagulation (CAFA) Study, Journal of the American College of Cardiology, 18, 349, 10.1016/0735-1097(91)90585-W · DOI · Paper page
  60. Corporative, 1990, The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators, New England Journal of Medicine, 323, 1505, 10.1056/NEJM199011293232201 · DOI · Paper page
  61. Solà-Morales Serra, 2005, Portable coagulometers: a systematic review of the evidence on self-management of oral anticoagulant treatment, Medicina Clinica (Barc), 124, 321
  62. DerSimonian, 1986, Meta-analysis in clinical trials, Controlled Clinical Trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
  63. Devereaux, 2001, Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study, BMJ, 323, 1, 10.1136/bmj.323.7323.1218 · DOI · Paper page
  64. Dickersin, 1994, Identifying relevant studies for systematic reviews, BMJ, 309, 1286, 10.1136/bmj.309.6964.1286 · DOI · Paper page
  65. 1993, Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group, Lancet, 342, 1255, 10.1016/0140-6736(93)92358-Z · DOI · Paper page
  66. Ezekowitz, 1992, Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators, New England Journal of Medicine, 327, 1406, 10.1056/NEJM199211123272002 · DOI · Paper page
  67. Fitzmaurice, 2001, Recommendations for patients undertaking self management of oral anticoagulation, BMJ, 323, 985, 10.1136/bmj.323.7319.985 · DOI
  68. Gadisseur, 2004, Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life, Journal of Thrombosis and Haemostasis, 2, 584, 10.1111/j.1538-7836.2004.00659.x · DOI
  69. Go, 2003, Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?, JAMA, 290, 2685, 10.1001/jama.290.20.2685 · DOI · Paper page
  70. Greenblatt, 2005, Interaction of warfarin with drugs, natural substances, and foods, Journal of Clinical Pharmacology, 45, 127, 10.1177/0091270004271404 · DOI · Paper page
  71. Heneghan, 2006, Self-monitoring of oral anticoagulation: a systematic review and meta-analysis, Lancet, 367, 404, 10.1016/S0140-6736(06)68139-7 · DOI · Paper page
  72. Heneghan, 2008, Oral Anticoagulation Therapy, 229, 10.1002/9780470696323.ch17 · DOI
  73. Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
  74. Hirsh, 1998, Oral anticoagulation mechanism of action, clinical effectiveness, and optimal therapeutic range, Chest, 114 Suppl, 445, 10.1378/chest.114.5_Supplement.445S · DOI · Paper page
  75. Hirsh, 2001, Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range, Chest, 119 Suppl 1, 8, 10.1378/chest.119.1_suppl.8S · DOI · Paper page
  76. Hylek, 1996, An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation, New England Journal of Medicine, 335, 540, 10.1056/NEJM199608223350802 · DOI · Paper page
  77. Manotti, 2001, Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated Program for Oral Anticoagulant Treatment), Haematologica, 86, 1060
  78. Montori, 2005, Randomized trials stopped early for benefit: a systematic review, JAMA, 294, 2203, 10.1001/jama.294.17.2203 · DOI · Paper page
  79. Poller, 2006, Quality assessment of CoaguChek point-of-care prothrombin time monitors: comparison of the European community-approved procedure and conventional external quality assessment, Clinical Chemistry, 52, 1843, 10.1373/clinchem.2006.071639 · doi:10.1373/clinchem.2006.071639
  80. Regier, 2006, Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy, CMAJ, 174, 1847, 10.1503/cmaj.051104 · DOI
  81. Sawicki, 2003, Self-management of oral anticoagulation: long-term results, Journal of Internal Medicine, 254, 515, 10.1046/j.1365-2796.2003.01215.x · doi:10.1046/j.1365-2796.2003.01215.x
  82. Siebenhofer, 2004, Systematic review of studies of self-management of oral anticoagulation, Thrombosis and Haemostasis, 91, 225, 10.1160/TH03-09-0598 · DOI
  83. 1996, Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial, Lancet, 348, 633, 10.1016/S0140-6736(96)03487-3 · DOI · Paper page
  84. Stafford, 1998, Recent national patterns of warfarin use in atrial fibrillation, Circulation, 97, 1231, 10.1161/01.CIR.97.13.1231 · DOI · Paper page
  85. Taborski, 1999, Cost-effectiveness of self-managed anticoagulant therapy in Germany, Seminars in Thrombosis and Hemostasis, 25, 103, 10.1055/s-2007-996432 · doi:10.1055/s-2007-996432
  86. Ødegaard, 2004, Self-management in anticoagulation--a meta-analysis, Tidsskrift for den Norske Laegeforening, 124, 2900
  87. Heneghan, 2006, Self-monitoring of oral anticoagulation: a systematic review and meta-analysis, Lancet, 367, 404, 10.1016/S0140-6736(06)68139-7 · DOI · Paper page

Cited by

See all 109

Metadata

Authors
Garcia-Alamino, J. M., Ward, A. M., Alonso-Coello, P., Perera, R., Bankhead, C., Fitzmaurice, D., & Heneghan, C. J.
Venue
Cochrane Database of Systematic Reviews
Published
2010-04-14
Issue
4
Pages
CD003839-CD003839
ISSN
1361-6137 (ISSN-L)
OpenAlex
W4231613903
Cited by
109
References
4
Type
reference entry
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Self-monitoring and self-management of oral anticoagulation. https://app.cochat.ai/papers/10.1002/14651858.cd003839.pub2
The paper
Garcia-Alamino, J. M., Ward, A. M., Alonso-Coello, P., Perera, R., Bankhead, C., Fitzmaurice, D., & Heneghan, C. J. (2010). Self-monitoring and self-management of oral anticoagulation. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd003839.pub2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.